Vivo Capital amasses over $1.2 bln for ninth fund
Vivo Capital has raised over $1.2 billion for its ninth fund, according to an SEC filing. No target was listed in the document. Vivo invests in healthcare companies in the U.S. and greater China.
4 June 2019•1 min read
